Literature DB >> 6417666

Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation.

R M Clancy, C A Dahinden, T E Hugli.   

Abstract

Release of arachidonic acid by the membrane phospholipase and metabolism by the 5-lipoxygenase pathway was examined in human polymorphonuclear leukocytes (PMNs). The 5-lipoxygenase pathway is activated when PMNs are given arachidonic acid in ethanol and there is extensive metabolism to 5-hydroxyicosatetraenoic acid (5-HETE) and leukotriene B4 (LTB4). This activation event was shown to be altered by the ethanol because resting PMNs given arachidonic acid with bovine serum albumin fail to metabolize arachidonic acid. However, cells activated by the inflammatory agents N-formyl-Met-Leu-Phe (fMLF) or complement component C5a recruit the 5-lipoxygenase to metabolize exogenous arachidonic acid to 5-HETE and LTB4. When PMNs were incubated with arachidonic acid-bovine serum albumin and challenged with fMLF or C5a (des-Arg-C5a) they produced 49-75 pmol of LTB4 and 310-440 pmol of 5-HETE per 10(7) cells. PMNs stimulated by fMLF or C5a (des-Arg-C5a) do not induce membrane phospholipases to mobilize endogenous arachidonic acid and neither 5-HETE nor LTB4 is formed. In contrast, PMN stimulation by the ionophore A23187 activates both the membrane phospholipase and the 5-lipoxygenase to produce 5-HETE and LTB4 from endogenous arachidonic acid. Our results indicate that the lipoxygenase pathway is inoperative in resting PMNs but can be recruited by chemotactic factors to act on arachidonate from extracellular sources. It was previously believed that formation of 5-HETE and LTB4 by the PMN depends solely on phospholipase to mobilize endogenous arachidonic acid. The results reported here refute this concept and indicate that the role of phospholipase activation in PMN may be overestimated. Therefore, subsequent involvement of lipoxygenase products in mediating stimulation of PMN by inflammatory factors (e.g., as in aggregation and chemotaxis) remains in question unless an exogenous source of arachidonate can be identified.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417666      PMCID: PMC390022          DOI: 10.1073/pnas.80.23.7200

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

2.  Stimulation of neutrophil oxidative metabolism by chemotactic peptides: influence of calcium ion concentration and cytochalasin B and comparison with stimulation by phorbol myristate acetate.

Authors:  J E Lehmeyer; R Snyderman; R B Johnston
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

3.  Receptor-mediated uptake and degradation of 125I-chemotactic peptide by human neutrophils.

Authors:  J Niedel; S Wilkinson; P Cuatrecasas
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

4.  Chemoattractants stimulate degradation of methylated phospholipids and release of arachidonic acid in rabbit leukocytes.

Authors:  F Hirata; B A Corcoran; K Venkatasubramanian; E Schiffmann; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

5.  Neutrophil aggregation and degranulation. Effect of arachidonic acid.

Authors:  J T O'Flaherty; H J Showell; E L Becker; P A Ward
Journal:  Am J Pathol       Date:  1979-05       Impact factor: 4.307

6.  Initiation of phospholipase A2 activity in human platelets by the calcium ion ionophore A23187.

Authors:  W C Pickett; R L Jesse; P Cohen
Journal:  Biochim Biophys Acta       Date:  1976-01-18

7.  Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187.

Authors:  P Borgeat; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

8.  Leukotriene C: a slow-reacting substance from murine mastocytoma cells.

Authors:  R C Murphy; S Hammarström; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

9.  Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.

Authors:  D E Chenoweth; T E Hugli
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

10.  Metabolism of arachidonic acid in polymorphonuclear leukocytes. Structural analysis of novel hydroxylated compounds.

Authors:  P Borgeat; B Samuelsson
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

View more
  38 in total

1.  Differential effects of lipoxygenase products on FMLP and LTB4 evoked neutrophil aggregation.

Authors:  J K Beckman; J C Gay; A R Brash; J N Lukens; J A Oates
Journal:  Lipids       Date:  1985-06       Impact factor: 1.880

2.  E-type prostaglandins but not iloprost inhibit platelet activating factor-induced generation of leukotriene B4 by human polymorphonuclear leukocytes.

Authors:  P Ney; K Schrör
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

Review 3.  Structure and function of the anaphylatoxins.

Authors:  T E Hugli
Journal:  Springer Semin Immunopathol       Date:  1984

4.  Interleukin-8 stimulates the formation of 15-hydroxy-eicosatetraenoic acid by human neutrophils in vitro.

Authors:  K Fogh; C G Larsen; L Iversen; K Kragballe
Journal:  Agents Actions       Date:  1992-03

5.  Activation of the human neutrophil 5-lipoxygenase by leukotriene B4.

Authors:  P P McDonald; S R McColl; P H Naccache; P Borgeat
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

6.  Thrombin-activated platelets promote leukotriene B4 synthesis in polymorphonuclear leucocytes stimulated by physiological agonists.

Authors:  R Palmantier; P Borgeat
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

7.  Leukotriene B4 promotes phospholipid acylation in human neutrophils.

Authors:  J S Tou; S Healey
Journal:  Lipids       Date:  1991-04       Impact factor: 1.880

8.  Oxidation of leukotrienes at the omega end: demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors.

Authors:  R M Clancy; C A Dahinden; T E Hugli
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

9.  Involvement of endogenous leukotriene B4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in rats.

Authors:  Caroline Bélanger; Hanan Elimam; Julie Lefebvre; Pierre Borgeat; Sylvie Marleau
Journal:  Immunology       Date:  2008-01-24       Impact factor: 7.397

Review 10.  Chemotactic peptides. Mechanisms, functions, and possible role in inflammatory bowel disease.

Authors:  C C Nast; L E LeDuc
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.